1. Home
  2. AMSF vs TOI Comparison

AMSF vs TOI Comparison

Compare AMSF & TOI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo AMERISAFE Inc.

AMSF

AMERISAFE Inc.

HOLD

Current Price

$33.81

Market Cap

584.3M

Sector

Finance

ML Signal

HOLD

Logo The Oncology Institute Inc.

TOI

The Oncology Institute Inc.

HOLD

Current Price

$5.23

Market Cap

565.9M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
AMSF
TOI
Founded
1985
2007
Country
United States
United States
Employees
N/A
641
Industry
Accident &Health Insurance
Medical/Nursing Services
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
584.3M
565.9M
IPO Year
1996
N/A

Fundamental Metrics

Financial Performance
Metric
AMSF
TOI
Price
$33.81
$5.23
Analyst Decision
Buy
Strong Buy
Analyst Count
3
3
Target Price
$46.33
$6.67
AVG Volume (30 Days)
218.0K
2.1M
Earning Date
04-22-2026
05-07-2026
Dividend Yield
8.61%
N/A
EPS Growth
N/A
N/A
EPS
0.43
N/A
Revenue
$317,252,000.00
N/A
Revenue This Year
$8.45
$30.15
Revenue Next Year
$6.03
$25.77
P/E Ratio
$77.97
N/A
Revenue Growth
2.66
N/A
52 Week Low
$29.42
$2.32
52 Week High
$47.86
$6.67

Technical Indicators

Market Signals
Indicator
AMSF
TOI
Relative Strength Index (RSI) 53.56 47.96
Support Level $32.11 $2.90
Resistance Level $34.15 $5.63
Average True Range (ATR) 1.01 0.45
MACD -0.17 -0.07
Stochastic Oscillator 37.70 12.73

Price Performance

Historical Comparison
AMSF
TOI

About AMSF AMERISAFE Inc.

AMERISAFE Inc is a specialty provider of workers' compensation insurance focused on small to mid-sized employers engaged in hazardous industries, principally construction, trucking, logging and lumber, agriculture, manufacturing, maritime, and telecommunications. The company generates a majority of its revenue in the form of premiums. The Company operates as a single reportable segment, Insurance Operations.

About TOI The Oncology Institute Inc.

The Oncology Institute Inc offers oncology care and treatment services to patients through several clinics located across the United States. It offers services such as infusion chemotherapy, oral drug chemotherapy, hospice and palliative care, autologous stem cell transplants, outpatient blood product transfusions, patient navigator programs, radiation oncology, and others on a fee or value-based model. Additionally, the company enrolls patients in clinical trials, where appropriate. The company has three operating segments: Specialty Pharmacy, Patient Services, and Clinical Trials and Other. Maximum revenue is generated from the Specialty Pharmacy segment, which operates specialty and retail pharmacies providing IV-infused, oral, injectable, and other medications for oncology treatment.

Share on Social Networks: